SCHEMBL15224297

SCHEMBL15224297

CN(C(=O)CCC(N)=O)C1CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
BACE1 P56817 2/20 0.44
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PKM P14618 1/20 0.40
NPBWR1 P48145 1/20 0.40
PDE4A P27815 3/20 0.40
PDE4B Q07343 3/20 0.40
PDE4C Q08493 3/20 0.40
PDE4D Q08499 3/20 0.40
PABPC1 P11940 1/20 0.40
FAAH O00519 1/20 0.40
PHGDH O43175 1/20 0.40
MGLL Q99685 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28230970 0.91 ALDH1A1 (0.50) ALDH1A1BACE1KMT2AMEN1NPSR1
SCHEMBL10723835 0.90 ALDH1A1 (0.59) ALDH1A1BACE1KMT2AMEN1NPSR1
SCHEMBL9496883 0.83 ALDH1A1 (0.53) ALDH1A1BACE1KMT2AMEN1NPSR1
SCHEMBL3364038 0.83 ALDH1A1 (0.53) ALDH1A1BACE1KMT2AMEN1NPSR1
SCHEMBL10722325 0.82 ALDH1A1 (0.56) ALDH1A1BACE1KMT2AMEN1NPSR1
SCHEMBL10453317 0.82 ALDH1A1 (0.56) ALDH1A1BACE1KMT2AMEN1NPSR1
SCHEMBL10721996 0.81 ALDH1A1 (0.54) ALDH1A1BACE1KMT2AMEN1NPSR1
SCHEMBL29051503 0.81 KMT2A (0.40) ALDH1A1KMT2AMEN1NPSR1PHGDH
SCHEMBL3363066 0.81 ALDH1A1 (0.54) ALDH1A1BACE1KMT2AMEN1NPSR1
SCHEMBL26211334 0.81 ALDH1A1 (0.54) ALDH1A1BACE1KMT2AMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 ALDH1A1 144/4885BACE1 26/4885KMT2A 3868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.